Vivo Capital VIII LLC 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Sale |
2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Vivo Capital VIII LLC | 2,073,005 5.500% |
-200,000 (-8.80%) |
Filing |
| 2021-02-18 4:50 pm Purchase |
2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Vivo Capital VIII LLC | 2,273,005 6.600% |
2,273,005 (New Position) |
Filing |